Gordon Sloan

1.6k total citations · 1 hit paper
22 papers, 930 citations indexed

About

Gordon Sloan is a scholar working on Physiology, Neurology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Gordon Sloan has authored 22 papers receiving a total of 930 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Physiology, 16 papers in Neurology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Gordon Sloan's work include Pain Mechanisms and Treatments (18 papers), Botulinum Toxin and Related Neurological Disorders (15 papers) and Diabetic Foot Ulcer Assessment and Management (3 papers). Gordon Sloan is often cited by papers focused on Pain Mechanisms and Treatments (18 papers), Botulinum Toxin and Related Neurological Disorders (15 papers) and Diabetic Foot Ulcer Assessment and Management (3 papers). Gordon Sloan collaborates with scholars based in United Kingdom, China and Australia. Gordon Sloan's co-authors include Solomon Tesfaye, Dinesh Selvarajah, Iain D. Wilkinson, Pallai Shillo, Uazman Alam, Praveen Anand, Rajiv Gandhi, Daisy Elliott, Irene Tracey and Jing Wu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Diabetes Care and Diabetes.

In The Last Decade

Gordon Sloan

22 papers receiving 917 citations

Hit Papers

Pathogenesis, diagnosis and clinical management of diabet... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers

Gordon Sloan
Pallai Shillo United Kingdom
Saad Javed United Kingdom
Catherine L. Stables United States
Simon E.M Eaton United Kingdom
Amy E. Rumora United States
Jill S. Gellett United States
Yūichi Murakawa United States
Pallai Shillo United Kingdom
Gordon Sloan
Citations per year, relative to Gordon Sloan Gordon Sloan (= 1×) peers Pallai Shillo

Countries citing papers authored by Gordon Sloan

Since Specialization
Citations

This map shows the geographic impact of Gordon Sloan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Sloan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Sloan more than expected).

Fields of papers citing papers by Gordon Sloan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gordon Sloan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Sloan. The network helps show where Gordon Sloan may publish in the future.

Co-authorship network of co-authors of Gordon Sloan

This figure shows the co-authorship network connecting the top 25 collaborators of Gordon Sloan. A scholar is included among the top collaborators of Gordon Sloan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gordon Sloan. Gordon Sloan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sloan, Gordon, et al.. (2024). Sheffield One‐Stop Service: A potential model to improve the screening uptake of diabetic peripheral neuropathy and other microvascular complications of diabetes. Journal of Diabetes Investigation. 15(10). 1355–1362. 1 indexed citations
2.
Sloan, Gordon, et al.. (2024). Increased Thalamocortical Functional Connectivity on Discontinuation of Treatment in Painful Diabetic Peripheral Neuropathy. Diabetes. 73(9). 1486–1494. 2 indexed citations
3.
Sloan, Gordon, Philippe Donatien, Pallai Shillo, et al.. (2024). Vascular and nerve biomarkers in thigh skin biopsies differentiate painful from painless diabetic peripheral neuropathy. SHILAP Revista de lepidopterología. 5. 1485420–1485420. 1 indexed citations
4.
Shillo, Pallai, Gordon Sloan, Dinesh Selvarajah, et al.. (2024). Reduced Thalamic γ-Aminobutyric Acid (GABA) in Painless but Not Painful Diabetic Peripheral Neuropathy. Diabetes. 73(8). 1317–1324. 2 indexed citations
5.
Elliott, Daisy, Gordon Sloan, Lynda Stevens, et al.. (2023). Female sex is a risk factor for painful diabetic peripheral neuropathy: the EURODIAB prospective diabetes complications study. Diabetologia. 67(1). 190–198. 26 indexed citations
6.
Selvarajah, Dinesh, Gordon Sloan, Iain D. Wilkinson, et al.. (2023). Structural Brain Alterations in Key Somatosensory and Nociceptive Regions in Diabetic Peripheral Neuropathy. Diabetes Care. 46(4). 777–785. 16 indexed citations
7.
Gandhi, Rajiv, Dinesh Selvarajah, Gordon Sloan, et al.. (2023). Preservation of thalamic neuronal function may be a prerequisite for pain perception in diabetic neuropathy: A magnetic resonance spectroscopy study. SHILAP Revista de lepidopterología. 3. 1086887–1086887. 3 indexed citations
9.
Sloan, Gordon, Dinesh Selvarajah, & Solomon Tesfaye. (2021). Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nature Reviews Endocrinology. 17(7). 400–420. 299 indexed citations breakdown →
10.
Wilkinson, Iain D., Alan Kelsall, Pallai Shillo, et al.. (2021). Somatosensory network functional connectivity differentiates clinical pain phenotypes in diabetic neuropathy. Diabetologia. 64(6). 1412–1421. 26 indexed citations
11.
Sloan, Gordon, Uazman Alam, Dinesh Selvarajah, & Solomon Tesfaye. (2021). The Treatment of Painful Diabetic Neuropathy. Current Diabetes Reviews. 18(5). e070721194556–e070721194556. 39 indexed citations
12.
Wilkinson, Iain D., Alan Kelsall, Pallai Shillo, et al.. (2020). Determinants of Treatment Response in Painful Diabetic Peripheral Neuropathy: A Combined Deep Sensory Phenotyping and Multimodal Brain MRI Study. Diabetes. 69(8). 1804–1814. 21 indexed citations
13.
Yang, Heng, et al.. (2020). New Perspective in Diabetic Neuropathy: From the Periphery to the Brain, a Call for Early Detection, and Precision Medicine. Frontiers in Endocrinology. 10. 929–929. 96 indexed citations
14.
Tesfaye, Solomon & Gordon Sloan. (2020). Diabetic Polyneuropathy – Advances in Diagnosis and Intervention Strategies. touchREVIEWS in Endocrinology. 16(1). 15–15. 13 indexed citations
15.
Alam, Uazman, Gordon Sloan, & Solomon Tesfaye. (2020). Treating Pain in Diabetic Neuropathy: Current and Developmental Drugs. Drugs. 80(4). 363–384. 64 indexed citations
16.
Langton, David, et al.. (2019). Bronchial thermoplasty increases airway volume measured by functional respiratory imaging. Respiratory Research. 20(1). 157–157. 21 indexed citations
17.
Shillo, Pallai, Gordon Sloan, Marni Greig, et al.. (2019). Painful and Painless Diabetic Neuropathies: What Is the Difference?. Current Diabetes Reports. 19(6). 32–32. 124 indexed citations
18.
Sloan, Gordon, Pallai Shillo, Dinesh Selvarajah, et al.. (2018). A new look at painful diabetic neuropathy. Diabetes Research and Clinical Practice. 144. 177–191. 130 indexed citations
19.
Sloan, Gordon, et al.. (2018). Prolonged diabetic ketoacidosis associated with canagliflozin. Endocrinology Diabetes and Metabolism Case Reports. 2018. 11 indexed citations
20.
Sloan, Gordon, et al.. (2017). A rare cause of metabolic acidosis: ketoacidosis in a non-diabetic lactating woman. Endocrinology Diabetes and Metabolism Case Reports. 2017. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026